vs
Pediatrix Medical Group, Inc.（MD）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Revolve Group, Inc.的1.5倍（$493.8M vs $324.4M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs 5.7%，领先1.1%），Revolve Group, Inc.同比增速更快（10.4% vs -1.7%），过去两年Revolve Group, Inc.的营收复合增速更高（9.5% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
MD vs RVLV — 直观对比
营收规模更大
MD
是对方的1.5倍
$324.4M
营收增速更快
RVLV
高出12.1%
-1.7%
净利率更高
MD
高出1.1%
5.7%
两年增速更快
RVLV
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $324.4M |
| 净利润 | $33.7M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | 9.9% | 6.3% |
| 净利率 | 6.8% | 5.7% |
| 营收同比 | -1.7% | 10.4% |
| 净利润同比 | 10.5% | 50.4% |
| 每股收益（稀释后） | $0.40 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDRVLV
| Q4 25 | $493.8M | $324.4M | ||
| Q3 25 | $492.9M | $295.6M | ||
| Q2 25 | $468.8M | $309.0M | ||
| Q1 25 | $458.4M | $296.7M | ||
| Q4 24 | $502.4M | $293.7M | ||
| Q3 24 | $511.2M | $283.1M | ||
| Q2 24 | $504.3M | $282.5M | ||
| Q1 24 | $495.1M | $270.6M |
净利润MDRVLV
| Q4 25 | $33.7M | $18.6M | ||
| Q3 25 | $71.7M | $21.2M | ||
| Q2 25 | $39.3M | $10.2M | ||
| Q1 25 | $20.7M | $11.8M | ||
| Q4 24 | $30.5M | $12.3M | ||
| Q3 24 | $19.4M | $11.0M | ||
| Q2 24 | $-153.0M | $15.4M | ||
| Q1 24 | $4.0M | $10.9M |
毛利率MDRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率MDRVLV
| Q4 25 | 9.9% | 6.3% | ||
| Q3 25 | 13.8% | 7.1% | ||
| Q2 25 | 12.8% | 5.8% | ||
| Q1 25 | 7.0% | 5.0% | ||
| Q4 24 | 7.8% | 3.9% | ||
| Q3 24 | 6.6% | 5.0% | ||
| Q2 24 | -31.3% | 5.8% | ||
| Q1 24 | 3.2% | 3.4% |
净利率MDRVLV
| Q4 25 | 6.8% | 5.7% | ||
| Q3 25 | 14.5% | 7.2% | ||
| Q2 25 | 8.4% | 3.3% | ||
| Q1 25 | 4.5% | 4.0% | ||
| Q4 24 | 6.1% | 4.2% | ||
| Q3 24 | 3.8% | 3.9% | ||
| Q2 24 | -30.3% | 5.4% | ||
| Q1 24 | 0.8% | 4.0% |
每股收益（稀释后）MDRVLV
| Q4 25 | $0.40 | $0.27 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.46 | $0.14 | ||
| Q1 25 | $0.24 | $0.16 | ||
| Q4 24 | $0.37 | $0.18 | ||
| Q3 24 | $0.23 | $0.15 | ||
| Q2 24 | $-1.84 | $0.21 | ||
| Q1 24 | $0.05 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $292.3M |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $512.5M |
| 总资产 | $2.2B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDRVLV
| Q4 25 | $375.2M | $292.3M | ||
| Q3 25 | $340.1M | $315.4M | ||
| Q2 25 | $224.7M | $310.7M | ||
| Q1 25 | $99.0M | $300.8M | ||
| Q4 24 | $229.9M | $256.6M | ||
| Q3 24 | $103.8M | $252.8M | ||
| Q2 24 | $19.4M | $244.7M | ||
| Q1 24 | $8.0M | $273.4M |
总债务MDRVLV
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MDRVLV
| Q4 25 | $865.9M | $512.5M | ||
| Q3 25 | $890.7M | $490.2M | ||
| Q2 25 | $833.8M | $468.6M | ||
| Q1 25 | $789.2M | $453.4M | ||
| Q4 24 | $764.9M | $437.8M | ||
| Q3 24 | $732.5M | $420.8M | ||
| Q2 24 | $706.5M | $405.8M | ||
| Q1 24 | $856.2M | $389.9M |
总资产MDRVLV
| Q4 25 | $2.2B | $765.0M | ||
| Q3 25 | $2.2B | $751.3M | ||
| Q2 25 | $2.1B | $722.9M | ||
| Q1 25 | $2.0B | $713.9M | ||
| Q4 24 | $2.2B | $665.5M | ||
| Q3 24 | $2.1B | $670.9M | ||
| Q2 24 | $2.0B | $657.8M | ||
| Q1 24 | $2.2B | $650.0M |
负债/权益比MDRVLV
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-13.3M |
| 自由现金流率自由现金流/营收 | — | -4.1% |
| 资本支出强度资本支出/营收 | — | 1.0% |
| 现金转化率经营现金流/净利润 | 3.39× | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流MDRVLV
| Q4 25 | $114.1M | $-10.2M | ||
| Q3 25 | $137.3M | $11.8M | ||
| Q2 25 | $137.2M | $12.6M | ||
| Q1 25 | $-117.5M | $45.1M | ||
| Q4 24 | $133.0M | $3.9M | ||
| Q3 24 | $91.8M | $9.1M | ||
| Q2 24 | $107.0M | $-24.7M | ||
| Q1 24 | $-125.2M | $38.4M |
自由现金流MDRVLV
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
自由现金流率MDRVLV
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度MDRVLV
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率MDRVLV
| Q4 25 | 3.39× | -0.55× | ||
| Q3 25 | 1.91× | 0.56× | ||
| Q2 25 | 3.49× | 1.24× | ||
| Q1 25 | -5.66× | 3.82× | ||
| Q4 24 | 4.36× | 0.32× | ||
| Q3 24 | 4.72× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | -31.03× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
